EUVIMEDEUVIMED entdecken
Open Access

Amiodarone’s impact on substrate mapping for scar-related ventricular tachycardia: Insights from personalized heart digital twins

Ryan Brody, Shane Loeffler, Adityo Prakosa, Ghassan Abboud, António Ferreira, Pedro Freitas, Pedro Adragao, Natalia A Trayanova

Heart Rhythm · 2026

DOI: 10.1016/j.hrthm.2026.04.032 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Heart Rhythm, 2026. Verfasst von Ryan Brody und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Engineering, Johns Hopkins University, Baltimore, Maryland; Alliance for Cardiovascular Diagnostic and Treatment Innovation,…. Hauptthemen laut MEDLINE: Tachycardia, Ventricular, Amiodarone, Cicatrix, Body Surface Potential Mapping. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, Leducq Foundation, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Substrate mapping and ablation for scar-related ventricular tachycardia (VT) are often performed with concomitant amiodarone (AMD), which can modify VT inducibility and alter electrogram (EGM) signatures of arrhythmogenic substrate. OBJECTIVE: This study aimed to evaluate how AMD influences VT inducibility and bipolar EGM markers using heart digital twins. METHODS: The effects of AMD at 2 therapeutic concentrations were characterized using heart digital twins incorporating patient-specific ischemic substrate distributions. VT inducibility was tested from multiple sites, and the reentrant circuits were characterized. Identified features of virtual electroanatomic maps included low-voltage, prolonged-duration, high-fractionation EGMs and isochronal crowding (IC) zones. Composite multiple-wavefront pacing maps were used to reduce electroanatomic map dependence on wavefront direction. RESULTS: AMD did not significantly change overall VT inducibility, although a nonsignificant trend toward fewer inducible sites emerged at higher doses. At the VT circuit level, several baseline circuits disappeared, new drug-associated pathways emerged, and persistent morphologies tended to exhibit longer cycle lengths. AMD broadened regions classified as abnormal by voltage, duration, and fractionation, expanding the apparent substrate and reducing mapping specificity. With a single pacing site, IC zones were within 9 mm of the critical isthmus, more targeted than abnormal signal features, and not appreciably expanded by AMD. Combining multiple pacing orientations markedly improved colocalization without loss of specificity. CONCLUSION: Concomitant AMD alters VT morphology and expands abnormal regions identified during substrate mapping, potentially obscuring critical ablation targets. Functional mapping strategies emphasizing IC and incorporating multiple-wavefront directions may improve long-term procedural success of scar-related VT ablation, particularly when AMD cannot be withdrawn.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tachycardia, VentricularAmiodaroneCicatrixBody Surface Potential MappingHeart Conduction SystemHumansAnti-Arrhythmia AgentsElectrophysiologic Techniques, CardiacCatheter Ablation

Stichwörter der Autor:innen

AblationAmiodaroneCardiac electrophysiologyComputational modelingSubstrate mappingVentricular tachycardia

Substanzen

AmiodaroneAnti-Arrhythmia Agents

Autor:innen und Institutionen

  • Department of Biomedical Engineering, Johns Hopkins University, Baltimore, Maryland; Alliance for Cardiovascular Diagnostic and Treatment Innovation, Johns Hopkins University, Baltimore, Maryland.
  • Department of Biomedical Engineering, Johns Hopkins University, Baltimore, Maryland; Alliance for Cardiovascular Diagnostic and Treatment Innovation, Johns Hopkins University, Baltimore, Maryland; School of Life Science…
  • Department of Cardiology, Hospital de Santa Cruz, Carnaxide, Lisbon, Portugal.
  • Department of Biomedical Engineering, Johns Hopkins University, Baltimore, Maryland; Alliance for Cardiovascular Diagnostic and Treatment Innovation, Johns Hopkins University, Baltimore, Maryland. Electronic address: nt…

Förderung

  • NHLBI NIH HHS
  • Leducq Foundation
  • National Institutes of Health
  • National Heart Lung and Blood Institute Division of Intramural Research

Zitieren

APA

Brody, R., Loeffler, S., Prakosa, A., Abboud, G., Ferreira, A., Freitas, P., Adragao, P., & Trayanova, N. A. (2026). Amiodarone’s impact on substrate mapping for scar-related ventricular tachycardia: Insights from personalized heart digital twins. Heart Rhythm. https://doi.org/10.1016/j.hrthm.2026.04.032

Vancouver

Brody R, Loeffler S, Prakosa A, Abboud G, Ferreira A, Freitas P, et al. Amiodarone’s impact on substrate mapping for scar-related ventricular tachycardia: Insights from personalized heart digital twins. Heart Rhythm. 2026. doi:10.1016/j.hrthm.2026.04.032

BibTeX
@article{Brody2026,
  author = {Brody, Ryan and Loeffler, Shane and Prakosa, Adityo and Abboud, Ghassan and Ferreira, António and Freitas, Pedro and Adragao, Pedro and Trayanova, Natalia A},
  title = {Amiodarone’s impact on substrate mapping for scar-related ventricular tachycardia: Insights from personalized heart digital twins},
  journal = {Heart Rhythm},
  year = {2026},
  doi = {10.1016/j.hrthm.2026.04.032}
}
Kostenlos starten →